{"id":728177,"date":"2023-02-02T08:15:59","date_gmt":"2023-02-02T13:15:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/"},"modified":"2023-02-02T08:15:59","modified_gmt":"2023-02-02T13:15:59","slug":"surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/","title":{"rendered":"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., Feb.  02, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K2OngQBO3jNtc8V7XjWY13HzoesS4k0lFgB0HUN_YubD62WPWZ1oAS3j0nTWc4M4h2qanZYGIew-aC8RHxjCFWwAMuFXEwiwz7rUZCWw6NU=\" rel=\"nofollow noopener\" target=\"_blank\">Surface Oncology<\/a> (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the 2023 Guggenheim Oncology Days conference in New York City on Thursday, February 9, 2023,\u00a0at 1:35 p.m. ET.<\/p>\n<p>A live audio webcast of the session may be accessed by visiting the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PEUuSKVBEFVQ-pYpvSuOMQdNgnQxRKnO2D0ZvQ4__P67LPNGOFJSV8K98IZatCHT2IaiTeviSostJt58p3RCBNcjbMmOf2a_OUsI0VO8VWYq8gX0egVhWs3i3SZfa3a3\" rel=\"nofollow noopener\" target=\"_blank\">Events page<\/a> on the Investors &amp; Media section of the Surface Oncology website. In addition, a replay of the webcast will be available on the company\u2019s website following the presentation.<\/p>\n<p>\n        <strong>About Surface Oncology<\/strong><br \/>\n        <br \/>Surface Oncology\u00a0is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned programs; SRF388, a Phase 2 program which targets IL-27, and SRF114, a Phase 1 program which selectively depletes regulatory T cells in the tumor microenvironment via targeting CCR8. In addition, Surface has two partnerships with major pharmaceutical companies; a collaboration with Novartis targeting CD73 (NZV930; Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (GSK4381562, formerly SRF813; Phase 1). Surface\u2019s novel, investigational cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response and may be used alone or in combination with other therapies. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AYD3xPrix6F_T5yG9NYVoiIAhUPvWoLTDEKTZR6Lsh7-RqxGgzGlAtT3vjnnUQhpG6GFSTrX2gqkz9rb3GHGySaSfasSNNL7mZScz5Wjs9bA_Xu1ZZ8GDsXt3YuFHzJDDYuJi1a99HnsY_QsWSh68El7OQBL4lNq7eYZ3fbGxiNsb0GquMWPoEOuXJVzN2kwe0YR7wx9Q8qmyejlAf8YIaZmkkAVv6My-jN1Z77cB17WiGTGtxiMAGv8aNtAEu8gGJk9hguu4t3OyX-96oBgDQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.surfaceoncology.com<\/a>.<\/p>\n<p>\n        <strong>Contact<\/strong><br \/>\n        <br \/>Scott Young<br \/>(617) 865-3250<br \/>syoung@surfaceoncology.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjIzNGU0OTktZTBiNC00NzU1LTk5NzctZjQ2YmVmYmFkZTc0LTExMDgzODI=\/tiny\/Surface-Oncology-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) &#8212; Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the 2023 Guggenheim Oncology Days conference in New York City on Thursday, February 9, 2023,\u00a0at 1:35 p.m. ET. A live audio webcast of the session may be accessed by visiting the Events page on the Investors &amp; Media section of the Surface Oncology website. In addition, a replay of the webcast will be available on the company\u2019s website following the presentation. About Surface Oncology Surface Oncology\u00a0is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-728177","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) &#8212; Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the 2023 Guggenheim Oncology Days conference in New York City on Thursday, February 9, 2023,\u00a0at 1:35 p.m. ET. A live audio webcast of the session may be accessed by visiting the Events page on the Investors &amp; Media section of the Surface Oncology website. In addition, a replay of the webcast will be available on the company\u2019s website following the presentation. About Surface Oncology Surface Oncology\u00a0is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline &hellip; Continue reading &quot;Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T13:15:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference\",\"datePublished\":\"2023-02-02T13:15:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/\"},\"wordCount\":230,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/\",\"name\":\"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=\",\"datePublished\":\"2023-02-02T13:15:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/","og_locale":"en_US","og_type":"article","og_title":"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) &#8212; Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the 2023 Guggenheim Oncology Days conference in New York City on Thursday, February 9, 2023,\u00a0at 1:35 p.m. ET. A live audio webcast of the session may be accessed by visiting the Events page on the Investors &amp; Media section of the Surface Oncology website. In addition, a replay of the webcast will be available on the company\u2019s website following the presentation. About Surface Oncology Surface Oncology\u00a0is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline &hellip; Continue reading \"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-02T13:15:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference","datePublished":"2023-02-02T13:15:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/"},"wordCount":230,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/","name":"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=","datePublished":"2023-02-02T13:15:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MTE5OCM1Mzg3MzYyIzIwOTY4MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surface-oncology-to-participate-in-the-2023-guggenheim-oncology-days-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=728177"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728177\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=728177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=728177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=728177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}